Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04692324
Status:
RECRUITING
Last Update Posted:
2023-11-18
First Post:
2020-12-29
Brief Title:
Cerebrospinal Fluid Biomarkers for Brain Tumors
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
Cerebrospinal Fluid Biomarkers for Brain Tumors
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study examines cerebrospinal biomarkers in patients with brain tumors A biomarker is a measurable indicator of the severity or presence of your disease state Collecting and storing samples of cerebrospinal fluid from patients with brain tumors to study in the laboratory may help doctors develop new strategies to better diagnose monitor and treat brain tumors
Detailed Description:
PRIMARY OBJECTIVE
I To collect cerebrospinal fluid CSF samples that can provide a resource to the research community for biomarker discovery in patients with gliomas
SECONDARY OBJECTIVE
I Evaluate the feasibility of serial CSF sampling from patients with brain tumors for longitudinal evaluation of tumor biomarkers
OUTLINE
Patients undergo collection of CSF samples via lumbar puncture at least 2 times Patients may undergo additional collection of additional CSF samples if they choose
After completion of study treatment patients are followed up periodically
I To collect cerebrospinal fluid CSF samples that can provide a resource to the research community for biomarker discovery in patients with gliomas
SECONDARY OBJECTIVE
I Evaluate the feasibility of serial CSF sampling from patients with brain tumors for longitudinal evaluation of tumor biomarkers
OUTLINE
Patients undergo collection of CSF samples via lumbar puncture at least 2 times Patients may undergo additional collection of additional CSF samples if they choose
After completion of study treatment patients are followed up periodically
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2021-02765 | REGISTRY | None | None |
| 20-008832 | OTHER | None | None |
| P30CA015083 | NIH | None | None |
| R61NS122096 | NIH | Mayo Clinic in Rochester | httpsreporternihgovquickSearchR61NS122096 |